StockDuty ← Dashboard Nov 06, 2026 01:59 PM ET
SignalCorporate

Aligos Therapeutics GAAP EPS of -$2.09 beats by $0.19, revenue of $2.83M misses by $2.71M

Aligos EPS beat by $0.19 while revenue missed by $2.71M.

Aligos EPS beat by $0.19 while revenue missed by $2.71M.
Aligos EPS beat by $0.19 while revenue missed by $2.71M. — impact context not separately stored; see What changed.
Sources